Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

118.82  +0.7 (+0.59%)

After market: 118.95 +0.13 (+0.11%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RBLX. RBLX was compared to 72 industry peers in the Entertainment industry. The financial health of RBLX is average, but there are quite some concerns on its profitability. RBLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RBLX has reported negative net income.
In the past year RBLX had a positive cash flow from operations.
RBLX had negative earnings in each of the past 5 years.
RBLX had a positive operating cash flow in each of the past 5 years.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -11.81%, RBLX is doing worse than 69.44% of the companies in the same industry.
Looking at the Return On Equity, with a value of -283.19%, RBLX is doing worse than 80.56% of the companies in the same industry.
Industry RankSector Rank
ROA -11.81%
ROE -283.19%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 77.92%, RBLX belongs to the top of the industry, outperforming 90.28% of the companies in the same industry.
In the last couple of years the Gross Margin of RBLX has remained more or less at the same level.
RBLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

6

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBLX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RBLX has been increased compared to 5 years ago.
Compared to 1 year ago, RBLX has an improved debt to assets ratio.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

RBLX has an Altman-Z score of 6.02. This indicates that RBLX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RBLX (6.02) is better than 84.72% of its industry peers.
The Debt to FCF ratio of RBLX is 1.15, which is an excellent value as it means it would take RBLX, only 1.15 years of fcf income to pay off all of its debts.
RBLX has a better Debt to FCF ratio (1.15) than 80.56% of its industry peers.
RBLX has a Debt/Equity ratio of 3.24. This is a high value indicating a heavy dependency on external financing.
RBLX has a worse Debt to Equity ratio (3.24) than 75.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF 1.15
Altman-Z 6.02
ROIC/WACCN/A
WACC8.97%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

RBLX has a Current Ratio of 1.02. This is a normal value and indicates that RBLX is financially healthy and should not expect problems in meeting its short term obligations.
RBLX has a Current ratio (1.02) which is comparable to the rest of the industry.
A Quick Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
RBLX has a Quick ratio of 1.02. This is comparable to the rest of the industry: RBLX outperforms 56.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

6

3. Growth

3.1 Past

RBLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.57%, which is quite impressive.
The Revenue has grown by 30.24% in the past year. This is a very strong growth!
RBLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 47.93% yearly.
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%

3.2 Future

Based on estimates for the next years, RBLX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.20% on average per year.
Based on estimates for the next years, RBLX will show a quite strong growth in Revenue. The Revenue will grow by 16.35% on average per year.
EPS Next Y0.82%
EPS Next 2Y8.65%
EPS Next 3Y13.2%
EPS Next 5YN/A
Revenue Next Year23.54%
Revenue Next 2Y22.46%
Revenue Next 3Y21.22%
Revenue Next 5Y16.35%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBLX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as RBLX.
Industry RankSector Rank
P/FCF 91.92
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as RBLX's earnings are expected to grow with 13.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.65%
EPS Next 3Y13.2%

More info and screens

0

5. Dividend

5.1 Amount

RBLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROBLOX CORP -CLASS A

NYSE:RBLX (7/25/2025, 8:20:00 PM)

After market: 118.95 +0.13 (+0.11%)

118.82

+0.7 (+0.59%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners78.64%
Inst Owner Change-0.13%
Ins Owners4.92%
Ins Owner Change1%
Market Cap80.59B
Analysts76.92
Price Target85.66 (-27.91%)
Short Float %3.96%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.92%
Min EPS beat(2)21.55%
Max EPS beat(2)28.29%
EPS beat(4)4
Avg EPS beat(4)20.7%
Min EPS beat(4)13.59%
Max EPS beat(4)28.29%
EPS beat(8)7
Avg EPS beat(8)15.39%
EPS beat(12)8
Avg EPS beat(12)3.94%
EPS beat(16)9
Avg EPS beat(16)-16.1%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)3.4%
Revenue beat(4)3
Avg Revenue beat(4)3.31%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)8.2%
Revenue beat(8)4
Avg Revenue beat(8)1.35%
Revenue beat(12)4
Avg Revenue beat(12)-5.15%
Revenue beat(16)4
Avg Revenue beat(16)-10.27%
PT rev (1m)13.32%
PT rev (3m)25.59%
EPS NQ rev (1m)4.71%
EPS NQ rev (3m)-7.45%
EPS NY rev (1m)2.53%
EPS NY rev (3m)6.26%
Revenue NQ rev (1m)1.9%
Revenue NQ rev (3m)3.61%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.01
P/FCF 91.92
P/OCF 78.45
P/B 259.4
P/tB 580.93
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)1.29
FCFY1.09%
OCF(TTM)1.51
OCFY1.27%
SpS5.66
BVpS0.46
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.81%
ROE -283.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.92%
FCFM 22.86%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF 1.15
Debt/EBITDA N/A
Cap/Depr 66.47%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 6.02
F-Score6
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
EPS Next Y0.82%
EPS Next 2Y8.65%
EPS Next 3Y13.2%
EPS Next 5YN/A
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%
Revenue Next Year23.54%
Revenue Next 2Y22.46%
Revenue Next 3Y21.22%
Revenue Next 5Y16.35%
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.48%
EBIT Next 3Y54.41%
EBIT Next 5Y39.08%
FCF growth 1Y1181.11%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y165.65%
OCF growth 3Y7.65%
OCF growth 5Y52.65%